Compare Bank of Montreal (BMO) vs BioNano Genomics Inc (BNGO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Bank of Montreal vs BioNano Genomics Inc — how do they compare? Bank of Montreal trades at $182.04 (market cap $126.83B), while BioNano Genomics Inc trades at $1.2 (market cap $13.66M). The key difference: Bank of Montreal is far larger — about 9284.8× BioNano Genomics Inc's market cap, and Bank of Montreal pays a 2.69% dividend while BioNano Genomics Inc pays none. Which is the better fit depends on your goals.
| BMO | BNGO | |
|---|---|---|
Market Cap | $126.83B | $13.66M |
Sector | Financials | Health |
52-Week High | $183.65 | $4.92 |
52-Week Low | $112.54 | $1.06 |
Dividend Yield | 2.69% | — |
Enterprise Value | — | $16.26M |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Bank of Montreal
Bank of Montreal is a diversified financial-services provider based in North America, operating four business segments: Canadian personal and commercial banking, U.S. P&C banking, wealth management, and capital markets. The bank's operations are primarily in Canada, with a material portion also in the U.S.
Read more on BMO →About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →
